Newsroom | 202988 results

Sorted by: Latest

Health
-

Ardent Announces Successful Amendment and Extension of Term Loan Facility

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it has successfully amended and extended its $777.5 million Term Loan Facility. The new terms reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 2.75% to Term SOFR plus 2.25%. The transaction extends the maturity of the facility to September 2032. “This transaction e...
-

AdaptHealth Corp. to Participate in Upcoming Investor Conference

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Jefferies Healthcare Services Conference, being held in Nashville, on Monday, September 29, 2025, including a fireside chat at 11:30 a.m. CST. The webcast link will be available on the Compa...
-

Freed Associates Announces CEO Succession Plan

OAKLAND, Calif.--(BUSINESS WIRE)--Freed Associates (Freed), a family-owned management consulting firm dedicated to healthcare, its employees and clients, today announced a formal leadership succession plan. After 34 years, founder and CEO, Dava Freed will retire in June of 2026. Alexandra (Allie) Freed, currently a senior leader with the firm, will become the company’s next CEO. Over the past 13 years, Allie has held multiple leadership roles at Freed, spearheading major client initiatives, exp...
-

MindMed Announces New Employee Inducement Grants

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 182,800 common shares of the Company (the "Options") with effective grant dates of September 15, 2025 and September 22, 2025, depending...
-

Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the acceptance of an oral presentation on results from the investigator-initiated CHOPIN randomized Phase 2 trial at the 2025 European Society for Medical Oncology (ESMO) Annual Congress. Principal Investigator Ellen Kapiteijn, MD, from Leiden University Medical Center’s Department of Medical Oncology, will...
-

New CEO Kate Bashir Leads EVCO Plastics to Earn Prestigious National Certification as a Women’s Business Enterprise

DEFOREST, Wis.--(BUSINESS WIRE)--EVCO Plastics, a leading custom plastics and contract manufacturer, is proud to announce its national certification as a Women’s Business Enterprise (WBE) by the Women’s Business Enterprise National Council (WBENC)—the most widely recognized and respected certifier of women-owned businesses in the U.S. Considered the gold standard for women-owned business certification in the United States, WBENC affirms that EVCO is at least 51% owned, controlled, operated and...
-

Same-Day Pharmacy Delivery Just Got Cooler: Walmart Now Delivers Refrigerated and Reconstituted Prescriptions Nationwide

BENTONVILLE, Ark.--(BUSINESS WIRE)--Walmart is taking pharmacy delivery to the next level. Same-Day Pharmacy Delivery now includes refrigerated and reconstituted medications—such as insulin, GLP-1s, and pediatric amoxicillin—and is available across the United States. With this move, Walmart becomes the first retailer to deliver refrigerated and reconstituted prescriptions alongside groceries and everyday essentials in a single, convenient online order. “We continue to unlock new levels of conve...
-

Riassunto: CelluForce lancia CelluShield™ – un rivestimento barriera innovativa per imballaggi flessibili riciclabili

MONTREAL--(BUSINESS WIRE)--CelluForce, il leader mondiale nei nanocristalli di cellulosa (CNC), oggi ha annunciato il lancio di CelluShield™, un rivestimento barriera a base biologica ad alte prestazioni, che consente imballaggi flessibili e riciclabili senza sacrificare la durata o la protezione di un prodotto. Realizzato con cellulosa rinnovabile e formulato come rivestimento a base idrica, CelluShield™ unisce eccellenti proprietà di barriera all'ossigeno e all'umidità e compatibilità con i f...
-

Samenvatting: CelluForce lanceert CelluShield™ – baanbrekende barrièrecoating voor recyclebare flexibele verpakkingen

MONTREAL--(BUSINESS WIRE)--CelluForce, wereldleider in cellulose nanokristallen (CNC), heeft vandaag de lancering aangekondigd van CelluShield™, een hoogwaardige, biogebaseerde barrièrecoating die recyclebare flexibele verpakkingen mogelijk maakt zonder dat dit ten koste gaat van de houdbaarheid of productbescherming. CelluShield™ is gemaakt van hernieuwbare cellulose en geformuleerd als een coating op waterbasis. Het combineert uitstekende zuurstof- en vochtbarrière-eigenschappen met compatibi...
-

Entrée en bourse d'Estithmar Holding dans l'indice FTSE Mid Cap

Doha, Qatar--(BUSINESS WIRE)--Le 18 septembre, Estithmar Holding Q.P.S.C., société qatarie, a été intégrée à l'indice FTSE Mid Cap suite à la revue semestrielle de la série d'indices FTSE Global Equity (GEIS) de septembre 2025. Ces changements entreront en vigueur le 18 septembre 2025. Cette intégration reflète la présence croissante d'Estithmar Holding sur les marchés régionaux et mondiaux, renforçant sa visibilité auprès des investisseurs internationaux et soulignant sa position parmi les pri...